Latest News
Please check your e-mail for a link to activate your account.

The True Price of High Drug Costs

As a future physician, I will be unable to fulfill my Hippocratic duty if patients can’t afford the drugs I prescribe to heal them.

Read more
The True Price of High Drug Costs
The True Price of High Drug Costs

Transparency in Drug Pricing: The Facts

Paying_for_Rx_Drugs.jpg

Read more
Prescription Drug Pricing: The Facts
Transparency in Drug Pricing: The Facts

Advocacy Day

YP-Baltimore celebrated Advocacy Day!

Advocacy_Day.jpg

On Thursday Feb. 2, 2017, members of YP-Baltimore participated in Advocacy Day hosted by the Maryland American Heart Association in Annapolis, MD. We met with our Senators and Delegates and advocated for the Prescription Drug Affordability Initiative. For some of us, this was our first time in Annapolis, and we experienced what it's like to converse with legislators who make important policy decisions on behalf of all Marylanders. 

Although residents have the right to meet with legislators to share their experiences and to communicate their feelings on important issues, only a select percentage are able to do so every year. So, we were glad to have this precious opportunity to speak face-to-face with legislators.

We came out of this event not only enriched in our understanding of important contexts surrounding issues currently on the policy table but also motivated to continue the advocacy efforts as campaigns heat up!

Advocacy Day
Advocacy Day

Senate Finance Committee: Briefing on Prescription Drug Pricing in Annapolis, MD

On January 24, YP-Baltimore chapter leaders Hussain and Minzhi attended a briefing in Annapolis, MD, which was called by the Senate Finance Committee to discuss more about the pricing of prescription drugs.

Key stakeholders were present, including leaders from Pharmaceutical Research and Manufactures Association of America (PhRMA), CareFirst Blue Cross Blue Shield, Pharmaceutical Care Management Association (leader of 12 pharmaceutical benefit managers), research professors from Johns Hopkins, Institute for Clinical and Economic Review, and the Special Assistant from the Office of the Attorney General.  There were four panels with two to four experts. Each expert made a brief presentation related to their perspective on prescription drug pricing and raised discussion on key challenges and recommendations.

Read more
Senate Finance Committee - Jan 24, 2017: Briefing on Prescription Drug Pricing
Senate Finance Committee: Briefing on Prescription Drug Pricing in Annapolis, MD

Read the blog at Young Professionals Chronic Disease Network
Latest News
Home